Key statistics
As of last trade, Novozymes A/S (0Q4U:LSE) traded at 379.50, 12.44% above the 52 week low of 337.50 set on Mar 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 383.85 |
|---|---|
| High | 379.50 |
| Low | 379.50 |
| Bid | 371.20 |
| Offer | 386.80 |
| Previous close | 378.35 |
| Average volume | 107.65k |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 294.93m |
| P/E (TTM) | 39.30 |
| Market cap | 155.42bn DKK |
| EPS (TTM) | 9.54 DKK |
| Annual div (ADY) | 6.50 DKK |
|---|---|
| Annual div yield (ADY) | 1.72% |
| Div ex-date | Mar 24 2026 |
| Div pay-date | Mar 26 2026 |
Data delayed at least 20 minutes, as of May 13 2026 13:28 BST.
More ▼
- Trading by management and close relations of management
- Novonesis delivered strong start to the year with 7% organic sales growth in Q1
- Interim report Q1 2026
- Novonesis expands global footprint with acquisition of production facility in Southeast Asia
- Trading by management and close relations of management
- Resolutions from the Annual General Meeting 2026
- Trading by management and close relations of management
- Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
- Novonesis issues EUR 1.7 billion senior unsecured notes
- Trading by management and close relations of management
More ▼
